Gbt

Developer of small molecules for the treatment of sickle cell disease

placeSan Francisco, California, United States calendar_todayFounded 2011 groups457 employees language gbt.com

Registered entities

Investor mix

10 investors on record; lead investors include Perceptive Advisors, Wellington, RA Capital Management, Deerfield; 1 has since exited.

Investor typeCountShare
Venture capital550%
Private equity220%
Bank & private debt110%
Other / undisclosed220%
Coming soon